The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju, H Li… - European journal of …, 2020 - Elsevier
This review fully describes the coronavirus 3CL pro peptidomimetic inhibitors and
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020.
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju… - European Journal of …, 2020 - europepmc.org
This review fully describes the coronavirus 3CL pro peptidomimetic inhibitors and
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Y Liu, C Liang, L Xin, X Ren, L Tian… - European journal …, 2020 - pubmed.ncbi.nlm.nih.gov
This review fully describes the coronavirus 3CL pro peptidomimetic inhibitors and
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju, H Li… - 2020 - expeditiorepositorio.utadeo.edu.co
3CLpro is a key enzyme for the maturation of all coronaviruses and has hence been
recognized as a potent drug target for the treatment of coronavirus infection. The present …
recognized as a potent drug target for the treatment of coronavirus infection. The present …
[HTML][HTML] The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju… - European Journal of …, 2020 - ncbi.nlm.nih.gov
This review fully describes the coronavirus 3CL pro peptidomimetic inhibitors and
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
[引用][C] The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju, H Li… - European Journal of …, 2020 - cir.nii.ac.jp
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020 |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020.
Y Liu, C Liang, L Xin, X Ren, L Tian, X Ju… - European Journal of …, 2020 - europepmc.org
This review fully describes the coronavirus 3CL pro peptidomimetic inhibitors and
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …
nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the …